Home » Healthcare » Pharmaceuticals » United Kingdom Gastrointestinal Products Market

United Kingdom Gastrointestinal Products Market By Devices (Endoscopy Devices, Ablation Devices, Motility Testing Devices, Biopsy Devices, Stenting Devices); By Indications (Gastrointestinal Cancers, Gastroesophageal Reflux Disease, Irritable Bowel Syndrome, Inflammatory Bowel Disease, Other Diseases); By End-User (Hospitals, Ambulatory Surgical Centers & Independent Surgical Centers, Clinics, Other End Users) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Summary
Table Of Content

REPORT ATTRIBUTE	DETAILS
Historical Period	2019-2022
Base Year	2023
Forecast Period	2024-2032
United Kingdom Gastrointestinal Products Market Size 2023	USD 571.75 million
United Kingdom Gastrointestinal Products Market, CAGR	6.01%
United Kingdom Gastrointestinal Products Market Size 2032	USD 967.42 million

Market Overview

The United Kingdom Gastrointestinal Products Market is projected to grow from USD 571.75 million in 2023 to USD 967.42 million by 2032, at a CAGR of 6.01%.

The United Kingdom gastrointestinal products market is driven by the increasing prevalence of gastrointestinal disorders, such as irritable bowel syndrome, acid reflux, and inflammatory bowel disease. Rising awareness about digestive health and the growing demand for effective treatment options further contribute to market growth. Additionally, advancements in biotechnology and pharmaceuticals have led to the development of more targeted therapies, enhancing treatment outcomes. The expanding geriatric population, which is more prone to gastrointestinal issues, is also fueling demand for these products. Trends in the market include the growing adoption of over-the-counter gastrointestinal medications and probiotics, as consumers seek self-care options. Furthermore, the increasing popularity of personalized medicine and the shift toward minimally invasive treatments are shaping the market. The rise in e-commerce and online retail platforms has made these products more accessible, driving consumer adoption. Overall, the market is poised for steady growth due to these drivers and trends.

The United Kingdom gastrointestinal products market is characterized by strong regional demand driven by the increasing prevalence of gastrointestinal disorders. Key players in the market include major medical device and pharmaceutical companies such as Medtronic, Stryker, Smith & Nephew, Karl Storz, and Ethicon Endo-Surgery, which offer a range of devices and therapeutic solutions for conditions like irritable bowel syndrome, inflammatory bowel disease, and gastrointestinal cancers. These companies are involved in the development and distribution of endoscopy devices, biopsy instruments, ablation devices, and other advanced gastrointestinal products. The market is supported by a robust healthcare infrastructure in regions like London, Manchester, Birmingham, and Scotland, where specialized hospitals and medical research centers are driving the demand for innovative gastrointestinal treatments. Furthermore, advancements in personalized medicine and the growing trend of self-care are shaping the competitive landscape, with companies focusing on delivering tailored and over-the-counter solutions to meet consumer needs.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

Market Insights

The United Kingdom gastrointestinal products market is projected to grow from USD 571.75 million in 2023 to USD 967.42 million by 2032, with a CAGR of 6.01%.
Increasing prevalence of gastrointestinal disorders such as IBS and GERD is driving the demand for innovative treatments and devices.
Advancements in digital health solutions and personalized medicine are reshaping treatment approaches in the gastrointestinal sector.
The market is highly competitive, with key players like Medtronic, Stryker, and Smith & Nephew focusing on product innovation and strategic collaborations.
Regulatory challenges and market saturation pose significant restraints, making differentiation and compliance crucial for success.
Regions like London and Manchester exhibit strong demand due to advanced healthcare infrastructure and high awareness of gastrointestinal health.
Growing consumer preference for preventive healthcare products, including probiotics and OTC medications, highlights a promising trend in the market.

Market Drivers

Rising Prevalence of Gastrointestinal Disorders

The growing prevalence of gastrointestinal (GI) disorders in the United Kingdom is a significant driver for the gastrointestinal products market. Conditions like irritable bowel syndrome (IBS), acid reflux, inflammatory bowel disease (IBD), and peptic ulcers are becoming more common, with an increasing number of individuals seeking medical interventions. As these disorders affect a large portion of the population, the demand for gastrointestinal medications and treatments continues to rise. This trend is particularly evident among the aging population, which is more susceptible to GI-related health issues.

Advancements in Biotechnology and Pharmaceuticals

Recent advancements in biotechnology and pharmaceutical research are accelerating the development of innovative gastrointestinal products. The introduction of more targeted therapies, biologics, and advanced drug formulations has enhanced the treatment options available for GI disorders. For example, the UK biopharmaceutical sector has been actively developing advanced therapeutics and personalized medicine solutions. These innovations not only improve patient outcomes but also provide more effective treatments for conditions that were previously difficult to manage. The development of personalized medicine, tailored to individual patient profiles, is also contributing to the market’s growth by offering customized therapeutic solutions.

Increasing Consumer Awareness and Demand for Probiotics

As consumers become more health-conscious, there is a growing demand for products that support digestive health. Probiotics, in particular, have gained popularity as a natural solution for improving gut health and managing conditions such as IBS and constipation. Consumers are increasingly seeking over-the-counter solutions, such as probiotics, antacids, and digestive enzymes, to manage mild gastrointestinal symptoms. This shift towards self-care and preventive measures is driving the demand for a variety of gastrointestinal products in the UK market.

Expansion of Online Retail and Accessibility

The rise of e-commerce platforms is making gastrointestinal products more accessible to consumers. Online retail channels allow consumers to conveniently purchase medications and supplements, often at competitive prices. For example, the UK has one of the most advanced e-commerce markets in Europe, with a significant portion of the population regularly shopping online. The growing trend of online shopping, combined with the expansion of delivery services, has further fueled the adoption of gastrointestinal products. This accessibility and convenience have made it easier for individuals to manage their digestive health, contributing to the overall growth of the market.

Market Trends

Growing Popularity of Over-the-Counter Products

One of the key trends in the United Kingdom gastrointestinal products market is the increasing preference for over-the-counter (OTC) medications. Consumers are becoming more proactive in managing their digestive health, opting for accessible and convenient solutions such as antacids, digestive enzymes, and probiotics. For instance, the sales value of OTC gastrointestinal treatments in Great Britain reached significant levels in recent years. OTC products, which can be purchased without a prescription, are gaining popularity as individuals seek immediate relief for mild gastrointestinal issues. This trend is particularly evident in younger populations, who are more likely to self-medicate for common GI problems like heartburn or bloating.

Shift Toward Personalized Medicine

Another notable trend is the growing shift toward personalized medicine within the gastrointestinal sector. With advances in genetic testing and biomarkers, healthcare providers can now offer more tailored treatment options for patients suffering from chronic gastrointestinal conditions. For instance, the NHS has been actively promoting personalized medicine to improve patient outcomes. Personalized therapies, such as biologics and targeted drugs, are designed to address the specific needs of individual patients, improving treatment outcomes. This trend is shaping the future of gastrointestinal care, offering patients more effective and customized solutions for managing their digestive health.

Advancements in Probiotics and Functional Foods

Probiotics are emerging as a major trend in the UK gastrointestinal products market, with an increasing number of consumers turning to these supplements to improve gut health and enhance digestion. Functional foods containing probiotics, prebiotics, and fiber are gaining traction as part of a broader health-conscious movement. These products, often marketed as natural alternatives to traditional medications, appeal to consumers looking for preventive and holistic approaches to digestive wellness. As more research highlights the benefits of gut health, the demand for probiotic-rich foods and supplements is expected to continue rising.

Integration of Digital Health Solutions

The integration of digital health solutions into gastrointestinal care is becoming increasingly common in the UK market. Mobile applications, wearable devices, and online platforms are being used to track symptoms, monitor treatment progress, and offer personalized recommendations. These digital tools enable patients to better manage their gastrointestinal conditions, while also providing healthcare professionals with valuable data to optimize treatment plans. The growing reliance on digital health technology is transforming the way gastrointestinal products are used and managed, further enhancing patient care and convenience.

Market Challenges Analysis

High Competition and Market Saturation

One of the significant challenges in the United Kingdom gastrointestinal products market is the intense competition and market saturation. The proliferation of over-the-counter medications, supplements, and prescription-based therapies has led to a crowded marketplace, making it difficult for new and existing brands to differentiate themselves. With a wide range of products available, including generic medications and natural alternatives, consumers have numerous options to choose from, which can dilute brand loyalty and create pricing pressure. Companies must continually innovate to offer superior products or unique value propositions to capture and retain consumer attention.

Regulatory Challenges and Safety Concerns

The gastrointestinal products market in the UK also faces challenges related to regulatory requirements and safety concerns. The strict regulatory environment, governed by agencies such as the Medicines and Healthcare products Regulatory Agency (MHRA), can make it difficult for companies to bring new products to market quickly. For instance, the Food Standards Agency (FSA) has reported that consumer trust in food safety remains high, but there is increased scrutiny on product ingredients and labelling. Additionally, with increasing concerns about the safety and efficacy of gastrointestinal treatments, manufacturers must navigate stringent testing and approval processes to ensure their products meet regulatory standards. The rise in consumer awareness and scrutiny around the ingredients and formulations of GI products further adds to the complexity, as brands must be transparent about product contents while ensuring compliance with safety regulations.

Market Opportunities

Rising Demand for Preventive Healthcare Products

A key market opportunity in the United Kingdom gastrointestinal products sector lies in the growing consumer focus on preventive healthcare. As individuals become more health-conscious, there is a noticeable shift toward adopting products that promote digestive wellness and overall gut health. Probiotics, digestive enzymes, and fiber-rich supplements are increasingly being sought after by consumers looking to prevent gastrointestinal issues before they arise. This trend opens doors for companies to introduce innovative preventive products that cater to the health-conscious market. By offering natural, over-the-counter solutions, businesses can tap into the expanding demand for self-care options, positioning themselves as leaders in the preventive health space.

Advancements in Personalized and Targeted Therapies

Another significant opportunity lies in the development of personalized and targeted therapies for gastrointestinal conditions. With the growing integration of genetic testing and advancements in precision medicine, there is an opportunity for companies to offer tailored treatments that address the specific needs of individuals with chronic gastrointestinal disorders. Biologics and advanced pharmaceutical therapies present an opportunity to improve outcomes for patients with conditions such as inflammatory bowel disease and IBS. The increasing awareness of personalized medicine among healthcare professionals and patients further supports the growth potential in this area. By investing in research and development to create customized therapies, companies can capitalize on this emerging trend and differentiate themselves in a competitive market.

Market Segmentation Analysis:

By Devices:

The United Kingdom gastrointestinal products market is segmented by devices, with significant contributions from endoscopy devices, ablation devices, motility testing devices, biopsy devices, and stenting devices. Endoscopy devices are widely used for diagnostic and therapeutic procedures, making them a dominant segment due to their role in detecting and treating various gastrointestinal conditions. Ablation devices, which are employed to treat tumors and lesions in the gastrointestinal tract, are also growing in demand, driven by advancements in minimally invasive treatments. Motility testing devices, used to assess gastrointestinal movement and function, are seeing an increase in adoption as more patients seek solutions for conditions like irritable bowel syndrome (IBS). Biopsy devices remain essential for diagnosing gastrointestinal cancers and other diseases, ensuring early detection and accurate diagnosis. Stenting devices, used to alleviate obstructions in the gastrointestinal tract, are expected to see continued demand as the incidence of digestive disorders rises, particularly in older populations.

By Indications:
The market is also segmented by indications, with key categories including gastrointestinal cancers, gastroesophageal reflux disease (GERD), irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), and other diseases. Gastrointestinal cancers, which include colorectal, esophageal, and stomach cancers, represent a significant portion of the market, as early detection and treatment options are critical. GERD is another prominent indication, driving demand for devices and therapies aimed at managing acid reflux. IBS and IBD are increasing in prevalence, with a growing number of individuals seeking solutions to manage symptoms effectively. As awareness of these conditions grows, so does the market for targeted treatments. Additionally, the “other diseases” category includes a wide range of gastrointestinal disorders, each contributing to the demand for specialized devices and therapeutic products, thereby broadening the market’s scope.

Segments:

Based on Devices:

Endoscopy Devices
Ablation Devices
Motility Testing Devices
Biopsy Devices
Stenting Devices

Based on Indications:

Gastrointestinal Cancers
Gastroesophageal Reflux Disease
Irritable Bowel Syndrome
Inflammatory Bowel Disease
Other Diseases

Based on End-User:

Hospitals
Ambulatory Surgical Centers & Independent Surgical Centers
Clinics
Other End Users

Based on the Geography:

London
Manchester
Birmingham
Scotland

Regional Analysis

London

The London region holds the largest market share, accounting for approximately 35% of the total market. As the capital city and economic hub of the UK, London benefits from a high concentration of healthcare facilities, medical research centers, and pharmaceutical companies. This region also experiences a higher prevalence of gastrointestinal disorders due to its large population, leading to greater demand for both over-the-counter products and advanced medical treatments. The presence of world-class hospitals and specialized gastrointestinal clinics further supports market growth in London, attracting both domestic and international patients seeking specialized care.

Manchester

In contrast, Manchester, the second-largest market, represents around 25% of the UK’s gastrointestinal products market. The city is a significant healthcare and academic center, with numerous institutions focused on medical research and gastrointestinal disease management. The presence of leading universities and hospitals contributes to the region’s growing market for advanced gastrointestinal treatments, including endoscopy devices, biopsy instruments, and biologic therapies. Additionally, Manchester’s diverse population has contributed to rising demand for digestive health products, particularly in preventive healthcare and self-care segments, such as probiotics and OTC medications.

Birmingham

Birmingham, which accounts for about 20% of the gastrointestinal products market, is another key regional player. The city’s strategic location in the Midlands and its well-established healthcare infrastructure make it a central hub for medical device distribution and healthcare services. Birmingham’s healthcare market benefits from both public and private healthcare sectors, with significant demand for gastrointestinal products in hospitals, clinics, and outpatient care centers. The increasing number of patients seeking treatment for gastrointestinal diseases such as IBS and IBD has boosted the demand for advanced medical devices and prescription treatments in the region.

Scotland

Scotland, though smaller in comparison, holds a 15% share of the UK gastrointestinal products market. The region is characterized by a growing elderly population, which is more susceptible to gastrointestinal disorders. As a result, there has been a steady increase in demand for digestive health products, particularly for conditions such as gastrointestinal cancers, GERD, and IBD. Healthcare providers in Scotland focus on improving access to cutting-edge treatments and preventive care solutions, making the region an important player in the overall market. Additionally, the rising trend of self-care and increased awareness about digestive health has contributed to the market’s expansion in Scotland.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key Player Analysis

SynMed
Penlon
Micro-Tech UK
Ethicon Endo-Surgery
Medtronic
Stryker
Smith & Nephew
Karl Storz
Hoya
Company 10
Company 11
Company 12
Company 13
Company 14

Competitive Analysis

The competitive landscape of the United Kingdom gastrointestinal products market is defined by the presence of leading players such as Medtronic, Stryker, Smith & Nephew, Karl Storz, and Ethicon Endo-Surgery. These companies dominate the market through their extensive product portfolios, technological advancements, and strategic initiatives. They focus on developing innovative devices such as endoscopy systems, ablation tools, and biopsy instruments to cater to the growing demand for minimally invasive and precision-based treatments.

Key players leverage collaborations, acquisitions, and product launches to strengthen their market positions and expand their customer base. For instance, advancements in digital health and personalized medicine have prompted these companies to integrate smart technologies into their offerings, enhancing patient outcomes and satisfaction. Additionally, their emphasis on R&D investments enables the development of next-generation products tailored to meet the specific needs of patients and healthcare providers. Despite their strong market presence, competition remains intense due to the emergence of new entrants and the availability of generic alternatives. For instance, the Medicines and Healthcare products Regulatory Agency (MHRA) enforces rigorous standards to ensure the safety and efficacy of pharmaceutical products. To maintain their competitive edge, leading players must address challenges such as stringent regulatory requirements and pricing pressures. Overall, their ability to innovate, adapt, and meet the evolving needs of the healthcare industry positions them as key contributors to market growth.

Recent Developments

In April 2023, Boston Scientific announced the launch of the EXALT Model B Single-use Bronchoscope, which expands its single-use endoscopy portfolio. This device is designed for diagnostic and therapeutic bronchoscopy procedures and offers high-resolution imaging and precise control.
In March 2023, Polifarma Spa expanded its gastrointestinal portfolio through a long-term distribution agreement with Devintec Pharma Sagl, a Lugano-based company known for pioneering substance-based medical devices and the Gelsectan brand.
In April 2023, Italian pharmaceutical innovator Azienda Farmaceutica Italiana partnered with TannerLAC, Inc. to distribute Hepilor, a medical device designed to protect the digestive system mucosa, throughout Latin America.
In May 2022, Dr. Reddy’s Laboratories Ltd. announced a partnership with South Korea’s HK inno.N Corporation to supply and commercialize HK inno.N’s patented novel molecule, Tegoprazan, for treating gastrointestinal diseases in India and six key emerging markets.
In March 2022, AbbVie Inc. received U.S. FDA approval for its novel drug, RINVOQ (upadacitinib), for the treatment of moderately to severely active ulcerative colitis.

Market Concentration & Characteristics

The United Kingdom gastrointestinal products market exhibits a moderate to high level of market concentration, with a few dominant players such as Medtronic, Stryker, Smith & Nephew, Karl Storz, and Ethicon Endo-Surgery leading the competitive landscape. These established companies hold significant market shares due to their extensive product portfolios, advanced technological capabilities, and strong distribution networks. The market is characterized by continuous innovation, with a focus on developing minimally invasive devices, precision-based therapies, and personalized treatment options to address complex gastrointestinal conditions. Despite the dominance of key players, the market also provides opportunities for smaller and emerging companies to capture niche segments through innovation and cost-effective solutions. The competitive environment is further shaped by strategic partnerships, mergers and acquisitions, and R&D investments aimed at enhancing product offerings and expanding geographic reach. Market characteristics include a growing demand for digital health technologies and preventive healthcare solutions, reflecting increased consumer awareness and evolving treatment preferences. Regulatory compliance and safety standards play a critical role in shaping product development and market entry. Overall, the market demonstrates a dynamic interplay of innovation, competition, and regulatory oversight, driving growth while addressing the diverse needs of patients and healthcare providers.

Report Coverage

The research report offers an in-depth analysis based on Devices, Indications, End-User and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

The United Kingdom gastrointestinal products market is expected to witness sustained growth driven by advancements in minimally invasive and precision-based therapies.
Increasing consumer awareness of gut health and preventive care will fuel the demand for OTC digestive health products.
Innovations in digital health technologies, such as AI-powered diagnostics, are likely to enhance treatment efficiency and patient outcomes.
Companies are anticipated to invest heavily in R&D to develop personalized medicine solutions tailored to individual gastrointestinal conditions.
Rising healthcare spending and improvements in the healthcare infrastructure will support market expansion in key regions.
Strategic collaborations between pharmaceutical and medical device companies are expected to accelerate product innovation and market penetration.
Emerging players focusing on cost-effective and niche solutions may create significant competition for established companies.
Regulatory frameworks will play a pivotal role in shaping the introduction of new gastrointestinal products and therapies.
The growing elderly population in the UK will likely drive demand for advanced gastrointestinal treatments and diagnostic tools.
Enhanced focus on sustainable and eco-friendly medical device production may influence product development and consumer preferences.

CHAPTER NO. 1 : INTRODUCTION 20

1.1.1. Report Description 20

Purpose of the Report 20

USP & Key Offerings 20

1.1.2. Key Benefits for Stakeholders 20

1.1.3. Target Audience 21

1.1.4. Report Scope 21

CHAPTER NO. 2 : EXECUTIVE SUMMARY 22

2.1. GASTROINTESTINAL PRODUCTS Market Snapshot 22

2.1.1. United Kingdom GASTROINTESTINAL PRODUCTS Market, 2018 – 2032 (USD Million) 23

CHAPTER NO. 3 : GEOPOLITICAL CRISIS IMPACT ANALYSIS 24

3.1. Russia-Ukraine and Israel-Palestine War Impacts 24

CHAPTER NO. 4 : GASTROINTESTINAL PRODUCTS MARKET – INDUSTRY ANALYSIS 25

4.1. Introduction 25

4.2. Market Drivers 26

4.2.1. GI Disorders on a Rise 26

4.2.2. New and innovative technologies driving the market 27

4.3. Market Restraints 28

4.3.1. Stringent Regulations 28

4.4. Market Opportunities 29

4.4.1. Market Opportunity Analysis 29

4.5. Porter’s Five Forces Analysis 30

4.6. Value Chain Analysis 31

4.7. Buying Criteria 32

CHAPTER NO. 5 : IMPORT EXPORT ANALYSIS 33

5.1. Import Analysis by United Kingdom 33

5.1.1. United Kingdom GASTROINTESTINAL PRODUCTS Market Import Volume/Revenue, By United Kingdom, 2018 – 2023 33

5.2. Export Analysis by United Kingdom 34

5.2.1. United Kingdom GASTROINTESTINAL PRODUCTS Market Export Volume/Revenue, By United Kingdom, 2018 – 2023 34

CHAPTER NO. 6 : DEMAND SUPPLY ANALYSIS 35

6.1. Demand Analysis by United Kingdom 35

6.1.1. United Kingdom GASTROINTESTINAL PRODUCTS Market Demand Volume/Revenue, By United Kingdom, 2018 – 2023 35

6.2. Supply Analysis by United Kingdom 36

6.2.1. United Kingdom GASTROINTESTINAL PRODUCTS Market Supply Volume/Revenue, By United Kingdom, 2018 – 2023 36

CHAPTER NO. 7 : PRODUCTION ANALYSIS 37

7.1. Production Analysis by United Kingdom 37

7.1.1. United Kingdom GASTROINTESTINAL PRODUCTS Market Production Volume/Revenue, By United Kingdom, 2018 – 2023 37

CHAPTER NO. 8 : PRICE ANALYSIS 38

8.1. Price Analysis by Devices 38

8.1.1. United Kingdom GASTROINTESTINAL PRODUCTS Market Price, By Devices, 2018 – 2023 38

8.1.2. United Kingdom Devices Market Price, By Devices, 2018 – 2023 38

CHAPTER NO. 9 : RAW MATERIALS ANALYSIS 39

9.1. Key Raw Materials and Suppliers 39

9.2. Key Raw Materials Price Trend 39

CHAPTER NO. 10 : MANUFACTURING COST ANALYSIS 40

10.1. Manufacturing Cost Analysis 40

10.2. Manufacturing Process 40

CHAPTER NO. 11 : ANALYSIS COMPETITIVE LANDSCAPE 41

11.1. Company Market Share Analysis – 2023 41

11.1.1. United Kingdom GASTROINTESTINAL PRODUCTS Market: Company Market Share, by Volume, 2023 41

11.1.2. United Kingdom GASTROINTESTINAL PRODUCTS Market: Company Market Share, by Revenue, 2023 42

11.1.3. United Kingdom GASTROINTESTINAL PRODUCTS Market: Top 6 Company Market Share, by Revenue, 2023 42

11.1.4. United Kingdom GASTROINTESTINAL PRODUCTS Market: Top 3 Company Market Share, by Revenue, 2023 43

11.2. United Kingdom GASTROINTESTINAL PRODUCTS Market Company Volume Market Share, 2023 44

11.3. United Kingdom GASTROINTESTINAL PRODUCTS Market Company Revenue Market Share, 2023 45

11.4. Company Assessment Metrics, 2023 46

11.4.1. Stars 46

11.4.2. Emerging Leaders 46

11.4.3. Pervasive Players 46

11.4.4. Participants 46

11.5. Start-ups /SMEs Assessment Metrics, 2023 46

11.5.1. Progressive Companies 46

11.5.2. Responsive Companies 46

11.5.3. Dynamic Companies 46

11.5.4. Starting Blocks 46

11.6. Strategic Developments 47

11.6.1. Acquisitions & Mergers 47

New Product Launch 47

United Kingdom Expansion 47

11.7. Key Players Product Matrix 48

CHAPTER NO. 12 : PESTEL & ADJACENT MARKET ANALYSIS 49

12.1. PESTEL 49

12.1.1. Political Factors 49

12.1.2. Economic Factors 49

12.1.3. Social Factors 49

12.1.4. Technological Factors 49

12.1.5. Environmental Factors 49

12.1.6. Legal Factors 49

12.2. Adjacent Market Analysis 49

CHAPTER NO. 13 : GASTROINTESTINAL PRODUCTS MARKET – BY DEVICES SEGMENT ANALYSIS 50

13.1. GASTROINTESTINAL PRODUCTS Market Overview, by Devices Segment 50

13.1.1. GASTROINTESTINAL PRODUCTS Market Revenue Share, By Devices, 2023 & 2032 51

13.1.2. GASTROINTESTINAL PRODUCTS Market Attractiveness Analysis, By Devices 52

13.1.3. Incremental Revenue Growth Opportunity, by Devices, 2024 – 2032 52

13.1.4. GASTROINTESTINAL PRODUCTS Market Revenue, By Devices, 2018, 2023, 2027 & 2032 53

13.2. Endoscopy Devices 54

13.3. Ablation Devices 55

13.4. Motility Testing Devices 56

13.5. Biospy Devices 57

13.6. Stenting Devices 58

CHAPTER NO. 14 : GASTROINTESTINAL PRODUCTS MARKET – BY INDICATIONS SEGMENT ANALYSIS 59

14.1. GASTROINTESTINAL PRODUCTS Market Overview, by Indications Segment 59

14.1.1. GASTROINTESTINAL PRODUCTS Market Revenue Share, By Indications, 2023 & 2032 60

14.1.2. GASTROINTESTINAL PRODUCTS Market Attractiveness Analysis, By Indications 61

14.1.3. Incremental Revenue Growth Opportunity, by Indications, 2024 – 2032 61

14.1.4. GASTROINTESTINAL PRODUCTS Market Revenue, By Indications, 2018, 2023, 2027 & 2032 62

14.2. Gastrointestinal Cancers 63

14.3. Gastroesophageal Reflux Disease 64

14.4. Irritable Bowl Syndrome 65

14.5. Inflammatory Bowel Disease 66

14.6. Other Disease 67

CHAPTER NO. 15 : GASTROINTESTINAL PRODUCTS MARKET – BY END-USER SEGMENT ANALYSIS 68

15.1. GASTROINTESTINAL PRODUCTS Market Overview, by End-user Segment 68

15.1.1. GASTROINTESTINAL PRODUCTS Market Revenue Share, By End-user, 2023 & 2032 69

15.1.2. GASTROINTESTINAL PRODUCTS Market Attractiveness Analysis, By End-user 70

15.1.3. Incremental Revenue Growth Opportunity, by End-user, 2024 – 2032 70

15.1.4. GASTROINTESTINAL PRODUCTS Market Revenue, By End-user, 2018, 2023, 2027 & 2032 71

15.2. Hospital 72

15.3. Ambulatory Surgical Center & Independent Surgical Center 73

15.4. Clinics 74

15.5. Other End Users 75

CHAPTER NO. 16 : COMPANY PROFILES 76

16.1. SynMed 76

16.1.1. Company Overview 76

16.1.2. Product Portfolio 76

16.1.3. Swot Analysis 76

16.1.4. Business Strategy 77

16.1.5. Financial Overview 77

16.2. Penlon 78

16.3. Micro-Tech UK 78

16.4. Ethicon Endo-Surgery 78

16.5. Medtronic 78

16.6. Stryker 78

16.7. Smith & Nephew 78

16.8. Karl Storz 78

16.9. Hoya 78

16.10. Company 10 78

16.11. Company 11 78

16.12. Company 12 78

16.13. Company 13 78

16.14. Company 14 78

List of Figures

FIG NO. 1. United Kingdom GASTROINTESTINAL PRODUCTS Market Revenue, 2018 – 2032 (USD Million) 22

FIG NO. 2. Porter’s Five Forces Analysis for United Kingdom GASTROINTESTINAL PRODUCTS Market 29

FIG NO. 3. Value Chain Analysis for United Kingdom GASTROINTESTINAL PRODUCTS Market 30

FIG NO. 4. United Kingdom GASTROINTESTINAL PRODUCTS Market Import Volume/Revenue, By United Kingdom, 2018 – 2023 32

FIG NO. 5. United Kingdom GASTROINTESTINAL PRODUCTS Market Export Volume/Revenue, By United Kingdom, 2018 – 2023 33

FIG NO. 6. United Kingdom GASTROINTESTINAL PRODUCTS Market Demand Volume/Revenue, By United Kingdom, 2018 – 2023 34

FIG NO. 7. United Kingdom GASTROINTESTINAL PRODUCTS Market Supply Volume/Revenue, By United Kingdom, 2018 – 2023 35

FIG NO. 8. United Kingdom GASTROINTESTINAL PRODUCTS Market Production Volume/Revenue, By United Kingdom, 2018 – 2023 36

FIG NO. 9. United Kingdom GASTROINTESTINAL PRODUCTS Market Price, By Devices, 2018 – 2023 37

FIG NO. 10. Raw Materials Price Trend Analysis, 2018 – 2023 38

FIG NO. 11. Manufacturing Cost Analysis 39

FIG NO. 12. Manufacturing Process 39

FIG NO. 13. Company Share Analysis, 2023 40

FIG NO. 14. Company Share Analysis, 2023 41

FIG NO. 15. Company Share Analysis, 2023 41

FIG NO. 16. Company Share Analysis, 2023 42

FIG NO. 17. GASTROINTESTINAL PRODUCTS Market – Company Volume Market Share, 2023 43

FIG NO. 18. GASTROINTESTINAL PRODUCTS Market – Company Revenue Market Share, 2023 44

FIG NO. 19. GASTROINTESTINAL PRODUCTS Market Revenue Share, By Devices, 2023 & 2032 50

FIG NO. 20. Market Attractiveness Analysis, By Devices 51

FIG NO. 21. Incremental Revenue Growth Opportunity by Devices, 2024 – 2032 51

FIG NO. 22. GASTROINTESTINAL PRODUCTS Market Revenue, By Devices, 2018, 2023, 2027 & 2032 52

FIG NO. 23. United Kingdom GASTROINTESTINAL PRODUCTS Market for Endoscopy Devices, Revenue (USD Million) 2018 – 2032 53

FIG NO. 24. United Kingdom GASTROINTESTINAL PRODUCTS Market for Ablation Devices, Revenue (USD Million) 2018 – 2032 54

FIG NO. 25. United Kingdom GASTROINTESTINAL PRODUCTS Market for Motility Testing Devices, Revenue (USD Million) 2018 – 2032 55

FIG NO. 26. United Kingdom GASTROINTESTINAL PRODUCTS Market for Biospy Devices, Revenue (USD Million) 2018 – 2032 56

FIG NO. 27. United Kingdom GASTROINTESTINAL PRODUCTS Market for Stenting Devices, Revenue (USD Million) 2018 – 2032 57

FIG NO. 28. GASTROINTESTINAL PRODUCTS Market Revenue Share, By Indications, 2023 & 2032 59

FIG NO. 29. Market Attractiveness Analysis, By Indications 60

FIG NO. 30. Incremental Revenue Growth Opportunity by Indications, 2024 – 2032 60

FIG NO. 31. GASTROINTESTINAL PRODUCTS Market Revenue, By Indications, 2018, 2023, 2027 & 2032 61

FIG NO. 32. United Kingdom GASTROINTESTINAL PRODUCTS Market for Gastrointestinal Cancers, Revenue (USD Million) 2018 – 2032 62

FIG NO. 33. United Kingdom GASTROINTESTINAL PRODUCTS Market for Gastroesophageal Reflux Disease, Revenue (USD Million) 2018 – 2032 63

FIG NO. 34. United Kingdom GASTROINTESTINAL PRODUCTS Market for Irritable Bowl Syndrome, Revenue (USD Million) 2018 – 2032 64

FIG NO. 35. United Kingdom GASTROINTESTINAL PRODUCTS Market for Inflammatory Bowel Disease, Revenue (USD Million) 2018 – 2032 65

FIG NO. 36. United Kingdom GASTROINTESTINAL PRODUCTS Market for Other Disease, Revenue (USD Million) 2018 – 2032 66

FIG NO. 37. GASTROINTESTINAL PRODUCTS Market Revenue Share, By End-user, 2023 & 2032 68

FIG NO. 38. Market Attractiveness Analysis, By End-user 69

FIG NO. 39. Incremental Revenue Growth Opportunity by End-user, 2024 – 2032 69

FIG NO. 40. GASTROINTESTINAL PRODUCTS Market Revenue, By End-user, 2018, 2023, 2027 & 2032 70

FIG NO. 41. United Kingdom GASTROINTESTINAL PRODUCTS Market for Hospital, Revenue (USD Million) 2018 – 2032 71

FIG NO. 42. United Kingdom GASTROINTESTINAL PRODUCTS Market for Ambulatory Surgical Center & Independent Surgical Center, Revenue (USD Million) 2018 – 2032 72

FIG NO. 43. United Kingdom GASTROINTESTINAL PRODUCTS Market for Clinics, Revenue (USD Million) 2018 – 2032 73

FIG NO. 44. United Kingdom GASTROINTESTINAL PRODUCTS Market for Other End Users, Revenue (USD Million) 2018 – 2032 74

FIG NO. 45. United Kingdom GASTROINTESTINAL PRODUCTS Market for End-user 5, Revenue (USD Million) 2018 – 2032 75

FIG NO. 46. GASTROINTESTINAL PRODUCTS Market Revenue Share, By Technology, 2023 & 2032 77

FIG NO. 47. Market Attractiveness Analysis, By Technology 78

FIG NO. 48. Incremental Revenue Growth Opportunity by Technology, 2024 – 2032 78

FIG NO. 49. GASTROINTESTINAL PRODUCTS Market Revenue, By Technology, 2018, 2023, 2027 & 2032 79

FIG NO. 50. United Kingdom GASTROINTESTINAL PRODUCTS Market for Technology 1, Revenue (USD Million) 2018 – 2032 80

FIG NO. 51. United Kingdom GASTROINTESTINAL PRODUCTS Market for Technology 2, Revenue (USD Million) 2018 – 2032 81

FIG NO. 52. United Kingdom GASTROINTESTINAL PRODUCTS Market for Technology 3, Revenue (USD Million) 2018 – 2032 82

FIG NO. 53. GASTROINTESTINAL PRODUCTS Market Revenue Share, By Distribution Channel, 2023 & 2032 84

FIG NO. 54. Market Attractiveness Analysis, By Distribution Channel 85

FIG NO. 55. Incremental Revenue Growth Opportunity by Distribution Channel, 2024 – 2032 85

FIG NO. 56. GASTROINTESTINAL PRODUCTS Market Revenue, By Distribution Channel, 2018, 2023, 2027 & 2032 86

FIG NO. 57. United Kingdom GASTROINTESTINAL PRODUCTS Market for Distribution Channel 1, Revenue (USD Million) 2018 – 2032 87

FIG NO. 58. United Kingdom GASTROINTESTINAL PRODUCTS Market for Distribution Channel 2, Revenue (USD Million) 2018 – 2032 88

FIG NO. 59. United Kingdom GASTROINTESTINAL PRODUCTS Market for Distribution Channel 3, Revenue (USD Million) 2018 – 2032 89

FIG NO. 60. United Kingdom GASTROINTESTINAL PRODUCTS Market for Distribution Channel 4, Revenue (USD Million) 2018 – 2032 90

FIG NO. 61. United Kingdom GASTROINTESTINAL PRODUCTS Market for Distribution Channel 5, Revenue (USD Million) 2018 – 2032 91

FIG NO. 62. Research Methodology – Detailed View 100

FIG NO. 63. Research Methodology 101

List of Tables

TABLE NO. 1. : United Kingdom GASTROINTESTINAL PRODUCTS Market: Snapshot 18

TABLE NO. 2. : Drivers for the GASTROINTESTINAL PRODUCTS Market: Impact Analysis 22

TABLE NO. 3. : Restraints for the GASTROINTESTINAL PRODUCTS Market: Impact Analysis 24

TABLE NO. 4. : United Kingdom GASTROINTESTINAL PRODUCTS Market Revenue, By Devices, 2018 – 2023 34

TABLE NO. 5. : Key Raw Materials & Suppliers 35

TABLE NO. 6. : United Kingdom GASTROINTESTINAL PRODUCTS Market Revenue, By Devices, 2018 – 2023 (USD Million) 89

TABLE NO. 7. : United Kingdom GASTROINTESTINAL PRODUCTS Market Revenue, By Devices, 2024 – 2032 (USD Million) 89

TABLE NO. 8. : United Kingdom GASTROINTESTINAL PRODUCTS Market Revenue, By Indications, 2018 – 2023 (USD Million) 90

TABLE NO. 9. : United Kingdom GASTROINTESTINAL PRODUCTS Market Revenue, By Indications, 2024 – 2032 (USD Million) 90

TABLE NO. 10. : United Kingdom GASTROINTESTINAL PRODUCTS Market Revenue, By End-user, 2018 – 2023 (USD Million) 91

TABLE NO. 11. : United Kingdom GASTROINTESTINAL PRODUCTS Market Revenue, By End-user, 2024 – 2032 (USD Million) 91

TABLE NO. 12. : United Kingdom GASTROINTESTINAL PRODUCTS Market Revenue, By Technology, 2018 – 2023 (USD Million) 92

TABLE NO. 13. : United Kingdom GASTROINTESTINAL PRODUCTS Market Revenue, By Technology, 2024 – 2032 (USD Million) 92

TABLE NO. 14. : United Kingdom GASTROINTESTINAL PRODUCTS Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 93

TABLE NO. 15. : United Kingdom GASTROINTESTINAL PRODUCTS Market Revenue, By Distribution Channel, 2024 – 2032 (USD Million) 93

Frequently Asked Questions

What is the current size of the United Kingdom Gastrointestinal Products market?

The United Kingdom gastrointestinal products market is valued at USD 571.75 million in 2023 and is projected to grow to USD 967.42 million by 2032, reflecting a compound annual growth rate (CAGR) of 6.01%.

What factors are driving the growth of the United Kingdom Gastrointestinal Products market?

The market growth is driven by the rising prevalence of gastrointestinal disorders such as IBS, GERD, and IBD, advancements in biotechnology and pharmaceuticals, increasing consumer awareness of gut health, and the expanding geriatric population. The growth of e-commerce and online retail platforms has also made gastrointestinal products more accessible, further boosting market demand.

What are the key segments within the United Kingdom Gastrointestinal Products market?

The key segments include:
• By Devices: Endoscopy devices, ablation devices, motility testing devices, biopsy devices, and stenting devices.
• By Indications: Gastrointestinal cancers, GERD, IBS, IBD, and other diseases.
• By End-User: Hospitals, ambulatory surgical centers, clinics, and other end users.
• By Geography: Regions such as London, Manchester, Birmingham, and Scotland.

What are some challenges faced by the United Kingdom Gastrointestinal Products market?

The market faces challenges such as high competition and market saturation, regulatory hurdles for product approval, and safety concerns surrounding certain gastrointestinal products. These factors create barriers for new entrants and put pressure on existing players to innovate and comply with stringent regulations.

Who are the major players in the United Kingdom Gastrointestinal Products market?

Key players include Medtronic, Stryker, Smith & Nephew, Karl Storz, and Ethicon Endo-Surgery. These companies are known for their extensive product portfolios, technological advancements, and strategic collaborations that address the growing demand for advanced gastrointestinal treatments.

Purchase Options

Single User

$2699

Multi User

$3699

Custom Report

$5699

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –